Variability in the distribution of genes encoding virulence factors and putative extracellular proteins of Streptococcus pyogenes in India, a region with high streptococcal disease burden, and implication for development of a regional multisubunit vaccine

Clinical and Vaccine Immunology

Volumn 19, Issue 11, 2012, Pages 1818-1825

  Sagar, Vivek ^a   Bergmann, René ^a   Nerlich, Andreas ^a,c   McMillan, David J ^b   Schmitz, D Patric Nitsche ^a   Chhatwal, Gursharan S ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; C5A PEPTIDASE; COLLAGEN LIKE SURFACE PROTEIN; HYPOTHETICAL PROTEIN; PUTATIVE SECRETED 5' NUCLEOTIDASE; R28 PROTEIN; SFBI PROTEIN; STREPTOCOCCUS ANTIGEN; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIBODY TITER; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CLINICAL FEATURE; CONTROLLED STUDY; EPIDEMIOLOGY; GENETIC VARIABILITY; HUMAN; INDIA; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; STREPTOCOCCUS PYOGENES; VALIDATION STUDY;

ADOLESCENT; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CHILD; GENETIC VARIATION; GENOTYPE; HUMANS; INDIA; MICROARRAY ANALYSIS; MOLECULAR TYPING; SEROEPIDEMIOLOGIC STUDIES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS PYOGENES; VACCINES, SUBUNIT; VIRULENCE FACTORS;

EID: 84868242571     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00112-12     Document Type: Article

References (44)

1. Agarwal AK, Yunus M, Ahmad J, Khan A. 1995. Rheumatic heart disease in India. J. R. Soc. Health 115:303-309.
2. Asrat D, et al. 2006. High diversity of group A streptococcal emm types among healthy schoolchildren in Ethiopia. Clin. Infect. Dis. 42:1362-1367.
3. Banks DJ, et al. 2004. Progress toward characterization of the group A streptococcus metagenome: complete genome sequence of a macrolideresistant serotype M6 strain. J. Infect. Dis. 190:727-738. (Pubitemid 39050003)
4. Beall B, Facklam R, Thompson T. 1996. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J. Clin. Microbiol. 34:953-958. (Pubitemid 26091514)
5. Beres SB, et al. 2006. Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A streptococcus. Proc. Natl. Acad. Sci. U. S. A. 103:7059-7064.
6. Bessen DE, Hollingshead SK. 1995. Horizontal transfer and mosaic-like emm gene structures in group A streptococci. Dev. Biol. Stand. 85:169-173.
7. Carapetis JR, Steer AC, Mulholland EK, Weber M. 2005. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5:685-694. (Pubitemid 41505357)
8. Cole JN, Henningham A, Gillen CM, Ramachandran V, Walker MJ. 2008. Human pathogenic streptococcal proteomics and vaccine development. Proteomics Clin. Appl. 2:387-410. (Pubitemid 351425367)
9. Cunningham MW. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470-511. (Pubitemid 30452618)
10. Dale JB, Penfound TA, Chiang EY, Walton WJ. 2011. New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against nonvaccine serotypes of group A streptococci. Vaccine 29:8175-8178.
11. Dey N, et al. 2005. High diversity of group A Streptococcal emm types in an Indian community: the need to tailor multivalent vaccines. Clin. Infect. Dis. 40:46-51. (Pubitemid 40053458)
12. Eshaghi M, Ali AM, Jamal F, Yusoff K. 2002. Existence of two emm-like "mrp" and "emm" genes in the mga regulon of the Streptococcus pyogenes strain ST4547. J. Biochem. Mol. Biol. Biophys. 6:23-28.
13. Ferretti JJ, et al. 2001. Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc. Natl. Acad. Sci. U. S. A. 98:4658-4663. (Pubitemid 32295032)
14. Hu MC, et al. 2002. Immunogenicity of a 26-valent group A streptococcal vaccine. Infect. Immun. 70:2171-2177. (Pubitemid 34242220)
15. Loimaranta V, et al. 2009. Leucine-rich repeats of bacterial surface proteins serve as common pattern recognition motifs of human scavenger receptor gp340. J. Biol. Chem. 284:18614-18623.
16. Lukomski S, et al. 2000. Identification and characterization of the scl gene encoding a group A streptococcus extracellular protein virulence factor with similarity to human collagen. Infect. Immun. 68:6542-6553. (Pubitemid 32463352)
17. Maione D, et al. 2005. Identification of a universal group B streptococcus vaccine by multiple genome screen. Science 309:148-150. (Pubitemid 40934997)
18. McMillan DJ, et al. 2006. Genes for the majority of group a streptococcal virulence factors and extracellular surface proteins do not confer an increased propensity to cause invasive disease. Clin. Infect. Dis. 43:884-891. (Pubitemid 44435516)
19. McMillan DJ, et al. 2007. Variations in the distribution of genes encoding virulence and extracellular proteins in group A streptococcus are largely restricted to 11 genomic loci. Microbes Infect. 9:259-270. (Pubitemid 46341928)
20. McShan WM, et al. 2008. Genome sequence of a nephritogenic and highly transformable M49 strain of Streptococcus pyogenes. J. Bacteriol. 190:7773-7785.
21. Miura K, et al. 2008. Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines. Vaccine 26:193-200. (Pubitemid 350266126)
22. Musser JM, et al. 1995. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infect. Immun. 63:994-1003.
23. Nitsche-Schmitz DP, et al. 2007. Group G streptococcal IgG binding molecules FOG and protein G have different impacts on opsonization by C1q. J. Biol. Chem. 282:17530-17536. (Pubitemid 47100297)
24. Pai R, et al. 2005. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J. Infect. Dis. 192:1988-1995. (Pubitemid 41681898)
25. Panchaud A, et al. 2009. M-protein and other intrinsic virulence factors of Streptococcus pyogenes are encoded on an ancient pathogenicity island. BMC Genomics 10:198. doi:10.1186/1471-2164-10-198.
26. Pfoh E, Wessels MR, Goldmann D, Lee GM. 2008. Burden and economic cost of group A streptococcal pharyngitis. Pediatrics 121: 229-234. (Pubitemid 351198443)
27. Rato MG, et al. 2011. Virulence gene pool detected in bovine group C Streptococcus dysgalactiae subsp. dysgalactiae isolates by use of a group A S. pyogenes virulence microarray. J. Clin. Microbiol. 49:2470-2479.
28. Reid SD, et al. 2002. Postgenomic analysis of four novel antigens of group a streptococcus: growth phase-dependent gene transcription and human serologic response. J. Bacteriol. 184:6316-6324. (Pubitemid 35265912)
29. Rodriguez-Ortega MJ, et al. 2006. Characterization and identification of vaccine candidate proteins through analysis of the group A streptococcus surface proteome. Nat. Biotechnol. 24:191-197. (Pubitemid 43221703)
30. Rohde M, et al. 2011. Differences in the aromatic domain of homologous streptococcal fibronectin-binding proteins trigger different cell invasion mechanisms and survival rates. Cell Microbiol. 13:450-468.
31. Sagar V, et al. 2004. Molecular heterogeneity among north Indian isolates of group A streptococcus. Lett. Appl. Microbiol. 39:84-88. (Pubitemid 38869812)
32. Sagar V, Kumar R, Ganguly NK, Chakraborti A. 2008. Comparative analysis of emm type pattern of group A streptococcus throat and skin isolates from India and their association with closely related SIC, a streptococcal virulence factor. BMC Microbiol. 8:150. doi:10.1186/1471-2180- 8-150.
33. Sakota V, et al. 2006. Genetically diverse group A streptococci from children in far-western Nepal share high genetic relatedness with isolates from other countries. J. Clin. Microbiol. 44:2160-2166. (Pubitemid 43902170)
34. Savage RS, et al. 2009. R/BHC: fast Bayesian hierarchical clustering for microarray data. BMC Bioinformatics 10:242.
35. Sehr P, Zumbach K, Pawlita M. 2001. A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J. Immunol. Methods 253:153-162. (Pubitemid 32522523)
36. Sette A, Rappuoli R. 2010. Reverse vaccinology: developing vaccines in the era of genomics. Immunity 33:530-541.
37. Smeesters PR, et al. 2006. Differences between Belgian and Brazilian group A streptococcus epidemiologic landscape. PLoS One 1:e10. doi: 10.1371/journal.pone.0000010.
38. Smoot JC, et al. 2002. Genome sequence and comparative microarray analysis of serotype M18 group A streptococcus strains associated with acute rheumatic fever outbreaks. Proc. Natl. Acad. Sci. U. S. A. 99:4668-4673. (Pubitemid 34286042)
39. Stalhammar-Carlemalm M, Areschoug T, Larsson C, Lindahl G. 1999. The R28 protein of Streptococcus pyogenes is related to several group B streptococcal surface proteins, confers protective immunity and promotes binding to human epithelial cells. Mol. Microbiol. 33:208-219. (Pubitemid 29304201)
40. Stalhammar-Carlemalm M, Areschoug T, Larsson C, Lindahl G. 2000. Cross-protection between group A and group B streptococci due to crossreacting surface proteins. J. Infect. Dis. 182:142-149. (Pubitemid 30497798)
41. Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR. 2009. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect. Dis. 9:611-616.
42. Talay SR, et al. 2000. Co-operative binding of human fibronectin to Sfbl protein triggers streptococcal invasion into respiratory epithelial cells. Cell Microbiol. 2:521-535. (Pubitemid 32049322)
43. Terao Y, et al. 2001. Fba, a novel fibronectin-binding protein from Streptococcus pyogenes, promotes bacterial entry into epithelial cells, and the fba gene is positively transcribed under the Mga regulator. Mol. Microbiol. 42:75-86. (Pubitemid 34212162)
44. Zagursky RJ, et al. 2000. Identification of a Haemophilus influenzae 5′- nucleotidase protein: cloning of the nucA gene and immunogenicity and characterization of the NucA protein. Infect. Immun. 68:2525-2534. (Pubitemid 30253822)